59 related articles for article (PubMed ID: 21084858)
1. Inhibition of tumor growth and vasculogenic mimicry by curcumin through down-regulation of the EphA2/PI3K/MMP pathway in a murine choroidal melanoma model.
Chen LX; He YJ; Zhao SZ; Wu JG; Wang JT; Zhu LM; Lin TT; Sun BC; Li XR
Cancer Biol Ther; 2011 Jan; 11(2):229-35. PubMed ID: 21084858
[TBL] [Abstract][Full Text] [Related]
2. Curcumin Inhibits Vasculogenic Mimicry Via Regulating ETS-1 in Renal Cell Carcinoma.
Chong Y; Xu S; Liu T; Guo P; Wang X; He D; Zhu G
Curr Cancer Drug Targets; 2024 Jan; ():. PubMed ID: 38299401
[TBL] [Abstract][Full Text] [Related]
3. Doxazosin inhibits vasculogenic mimicry in human non‑small cell lung cancer through inhibition of the VEGF‑A/VE‑cadherin/mTOR/MMP pathway.
Hsu JL; Leu WJ; Hsu LC; Hsieh CH; Guh JH
Oncol Lett; 2024 Apr; 27(4):170. PubMed ID: 38455663
[TBL] [Abstract][Full Text] [Related]
4. LIFU/MMP-2 dual-responsive release of repurposed drug disulfiram from nanodroplets for inhibiting vasculogenic mimicry and lung metastasis in triple-negative breast cancer.
Liu Y; Tang R; Cao Y; Wu N; Qin Q; Chen Y; Wei X; Ren J; Sun Y; Zhou H; Zhou Y; Li P
J Nanobiotechnology; 2024 Apr; 22(1):209. PubMed ID: 38664830
[TBL] [Abstract][Full Text] [Related]
5. RIPK1-dependent necroptosis promotes vasculogenic mimicry formation via eIF4E in triple-negative breast cancer.
Li F; Sun H; Yu Y; Che N; Han J; Cheng R; Zhao N; Guo Y; Huang C; Zhang D
Cell Death Dis; 2023 May; 14(5):335. PubMed ID: 37217473
[TBL] [Abstract][Full Text] [Related]
6. Endothelium-Dependent Induction of Vasculogenic Mimicry in Human Triple-Negative Breast Cancer Cells Is Inhibited by Calcitriol and Curcumin.
Morales-Guadarrama G; Méndez-Pérez EA; García-Quiroz J; Avila E; García-Becerra R; Zentella-Dehesa A; Larrea F; Díaz L
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887002
[TBL] [Abstract][Full Text] [Related]
7. Vasculogenic Mimicry-An Overview.
Marques Dos Reis E; Vieira Berti F
Methods Mol Biol; 2022; 2514():3-13. PubMed ID: 35771413
[TBL] [Abstract][Full Text] [Related]
8. The Role of Metalloproteinases and Their Tissue Inhibitors on Ocular Diseases: Focusing on Potential Mechanisms.
Caban M; Owczarek K; Lewandowska U
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457074
[TBL] [Abstract][Full Text] [Related]
9. Prognostic and Functional Analysis of
Mei S; Li Y; Kang X
Dis Markers; 2022; 2022():4143447. PubMed ID: 35432628
[TBL] [Abstract][Full Text] [Related]
10. Robust radiosensitization of hemoglobin-curcumin nanoparticles suppresses hypoxic hepatocellular carcinoma.
Gao R; Gu Y; Yang Y; He Y; Huang W; Sun T; Tang Z; Wang Y; Yang W
J Nanobiotechnology; 2022 Mar; 20(1):115. PubMed ID: 35248069
[TBL] [Abstract][Full Text] [Related]
11. Biomedical Applications and Bioavailability of Curcumin-An Updated Overview.
Sohn SI; Priya A; Balasubramaniam B; Muthuramalingam P; Sivasankar C; Selvaraj A; Valliammai A; Jothi R; Pandian S
Pharmaceutics; 2021 Dec; 13(12):. PubMed ID: 34959384
[TBL] [Abstract][Full Text] [Related]
12. New Peptide-Drug Conjugates for Precise Targeting of SORT1-Mediated Vasculogenic Mimicry in the Tumor Microenvironment of TNBC-Derived MDA-MB-231 Breast and Ovarian ES-2 Clear Cell Carcinoma Cells.
Charfi C; Demeule M; Currie JC; Larocque A; Zgheib A; Danalache BA; Ouanouki A; Béliveau R; Marsolais C; Annabi B
Front Oncol; 2021; 11():760787. PubMed ID: 34751242
[TBL] [Abstract][Full Text] [Related]
13. Molecular Mechanisms of Antiproliferative and Apoptosis Activity by 1,5-Bis(4-Hydroxy-3-Methoxyphenyl)1,4-Pentadiene-3-one (MS13) on Human Non-Small Cell Lung Cancer Cells.
Wan Mohd Tajuddin WNB; Abas F; Othman I; Naidu R
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299042
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia-dependent drivers of melanoma progression.
D'Aguanno S; Mallone F; Marenco M; Del Bufalo D; Moramarco A
J Exp Clin Cancer Res; 2021 May; 40(1):159. PubMed ID: 33964953
[TBL] [Abstract][Full Text] [Related]
15. Curcumin, a Multifaceted Hormetic Agent, Mediates an Intricate Crosstalk between Mitochondrial Turnover, Autophagy, and Apoptosis.
Rainey NE; Moustapha A; Petit PX
Oxid Med Cell Longev; 2020; 2020():3656419. PubMed ID: 32765806
[TBL] [Abstract][Full Text] [Related]
16. Vascular mimicry: changing the therapeutic paradigms in cancer.
Fathi Maroufi N; Taefehshokr S; Rashidi MR; Taefehshokr N; Khoshakhlagh M; Isazadeh A; Mokarizadeh N; Baradaran B; Nouri M
Mol Biol Rep; 2020 Jun; 47(6):4749-4765. PubMed ID: 32424524
[TBL] [Abstract][Full Text] [Related]
17. The EMT transcription factor, Twist1, as a novel therapeutic target for pulmonary sarcomatoid carcinomas.
Liu T; Zhao X; Zheng X; Zheng Y; Dong X; Zhao N; Liao S; Sun B
Int J Oncol; 2020 Mar; 56(3):750-760. PubMed ID: 32124963
[TBL] [Abstract][Full Text] [Related]
18. Brucine Suppresses Vasculogenic Mimicry in Human Triple-Negative Breast Cancer Cell Line MDA-MB-231.
Xu MR; Wei PF; Suo MZ; Hu Y; Ding W; Su L; Zhu YD; Song WJ; Tang GH; Zhang M; Li P
Biomed Res Int; 2019; 2019():6543230. PubMed ID: 30723742
[TBL] [Abstract][Full Text] [Related]
19. Kinase-targeted cancer therapies: progress, challenges and future directions.
Bhullar KS; Lagarón NO; McGowan EM; Parmar I; Jha A; Hubbard BP; Rupasinghe HPV
Mol Cancer; 2018 Feb; 17(1):48. PubMed ID: 29455673
[TBL] [Abstract][Full Text] [Related]
20. Low dosage of arsenic trioxide inhibits vasculogenic mimicry in hepatoblastoma without cell apoptosis.
Zhang F; Zhang CM; Li S; Wang KK; Guo BB; Fu Y; Liu LY; Zhang Y; Jiang HY; Wu CJ
Mol Med Rep; 2018 Jan; 17(1):1573-1582. PubMed ID: 29138840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
